Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, April 25, 2019

Budget win for brain disorders

Useless unless there is a strategy being followed to solve exact brain problems. And as for stroke there is NO STRATEGY AND NO LEADERSHIP.  So any stroke research is useless. Notice the 'models of care' NOT models of results.

Tyranny of low expectations in full display here. Just trying to 'care' for patients, NOT cure them. 

Budget win for brain disorders


The 2019 Federal Budget has delivered a win for people living with brain disorders in Australia, with a $7million funding boost for research aimed at developing improved models of care.
The clinical and research translation program, led by the Mindgardens Neuroscience Network (Mindgardens), will build new models of care to address the staggering burden of brain disorders in Australia. The disease burden associated with neurological, mental health and substance use disorders is in excess of $74 billion per annum and currently accounts for 20.5 per cent of disability-adjusted life years, nearly twice the global figure of 11.1 per cent illustrating the scale of the health care challenge. Between 2010 and 2017 substance misuse (drugs, alcohol) grew at 24.7 per cent, followed by neurological disorders at 15.6 per cent and mental health disorders by 8.6 per cent.
Funding for Mindgardens will support a series of pilot programs to develop new models of care to target the three principal areas of brain health:
(1) Neurological conditions, including developmental disorders, stroke and dementia,
(2) Mental Health, and
(3) Drug, alcohol and addiction disorders.
Pilot programs will include Apex Clinics, a ‘one-stop hub’ assessment and review of all patients with neurological, mental health or addiction brain disorders; integrated community hubs, providing customised and targeted community services offering the best evidence-based care to patients and linked to general practice; innovative data technologies to build prevention tools to support early intervention for both the patient and the clinician.
14328_NEU_Mindgardens new models of care graphic_$7mil_V4
Says Professor Helen Christensen AO, Interim Co-CEO of Mindgardens: “our current models of care treat individual disorders in a siloed manner. These disorders are frequently coexisting, they share brain mechanisms and behavioural patterns. We need to take a helicopter view that cuts across siloed service provision, creating better and more comprehensive care”.
Mindgardens aims to become the Australian Comprehensive Brain Disorder Centre for clinical care, research and innovation where pilot programs like Apex Clinics, Integrated Community Hubs and Preventative Technologies can be developed and then rolled out nationally to support all Australians living with a brain disorder.
Professor Peter Schofield AO, Interim Co-CEO of Mindgardens says: “linking outstanding patient care with world-class research is the way to mutually leverage research discovery and treatment innovation.
This has been demonstrated in cancer care where Comprehensive Cancer Centres have had great success in steering research towards the clinical problems of patients and bringing the benefits of research into patient care”.
“Our aim is to become an international leading precinct for innovative research and compassionate healthcare for all brain disorders,” says Professor Schofield.

No comments:

Post a Comment